Total Payments
$973.09
2024 Payments
$175.72
Companies
24
Transactions
54
Medicare Patients
72,648
Medicare Billing
$11.6M
Payment Breakdown by Category
Food & Beverage$924.21 (95.0%)
Education$48.88 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $924.21 | 51 | 95.0% |
| Education | $48.88 | 3 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $188.34 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $150.73 | 10 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $93.16 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $91.94 | 5 | $0 (2019) |
| PFIZER INC. | $63.82 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $34.01 | 2 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $31.25 | 2 | $0 (2023) |
| Seagen Inc. | $30.56 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $28.84 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $25.62 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.72 | 9 | Novartis Pharmaceuticals Corporation ($49.93) |
| 2023 | $141.04 | 7 | Janssen Biotech, Inc. ($28.84) |
| 2022 | $160.88 | 9 | E.R. Squibb & Sons, L.L.C. ($30.91) |
| 2021 | $28.79 | 2 | GlaxoSmithKline, LLC. ($16.87) |
| 2020 | $120.71 | 8 | E.R. Squibb & Sons, L.L.C. ($48.06) |
| 2019 | $251.68 | 15 | Merck Sharp & Dohme Corporation ($81.06) |
| 2018 | $44.27 | 3 | Helsinn Therapeutics (U.S.), Inc. ($17.62) |
| 2017 | $50.00 | 1 | PFIZER INC. ($50.00) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Oncology | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $15.96 | General |
| 08/02/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: Oncology | ||||||
| 05/23/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $34.89 | General |
| Category: Oncology | ||||||
| 02/13/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/15/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Oncology | ||||||
| 09/29/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CELLT | ||||||
| 03/09/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $28.84 | General |
| 02/23/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/10/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 01/06/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Oncology | ||||||
| 11/01/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Oncology | ||||||
| 08/24/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Hematology | ||||||
| 06/07/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2022 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/06/2022 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 03/15/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Oncology | ||||||
| 02/18/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $15.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 83 | 16,713 | 178,926 | $10.7M | $2.2M |
| 2022 | 80 | 16,487 | 171,938 | $11.5M | $2.5M |
| 2021 | 83 | 17,493 | 293,906 | $13.4M | $2.9M |
| 2020 | 88 | 21,955 | 431,064 | $18.8M | $4.0M |
Total Patients
72,648
Total Services
1,075,834
Medicare Billing
$11.6M
Procedure Codes
334
All Medicare Procedures & Services
334 procedure records from CMS Medicare Utilization — Page 1 of 14
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 31 | 22,801 | $3.1M | $990,073 | 32.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 62 | 10,020 | $521,040 | $185,385 | 35.6% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 71 | 9,000 | $675,000 | $147,155 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 482 | 1,283 | $284,826 | $119,373 | 41.9% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 13 | 3,120 | $374,400 | $104,891 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 684 | 1,224 | $214,375 | $76,858 | 35.9% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 89 | 102 | $617,508 | $73,297 | 11.9% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 61 | 9,520 | $380,800 | $56,076 | 14.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 117 | 484 | $218,768 | $46,334 | 21.2% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 105 | 120 | $131,040 | $23,780 | 18.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,087 | 2,794 | $128,524 | $23,430 | 18.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 1,073 | 2,792 | $254,072 | $21,227 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 156 | $58,032 | $20,835 | 35.9% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 111 | 123 | $492,123 | $19,472 | 4.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 111 | 376 | $28,200 | $17,872 | 63.4% |
| 80076 | Liver function blood test panel | Office | 2023 | 973 | 2,028 | $294,060 | $16,232 | 5.5% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 17 | 19 | $115,387 | $13,249 | 11.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 969 | 2,023 | $111,265 | $11,976 | 10.8% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 16 | 29 | $43,500 | $10,639 | 24.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 123 | 236 | $79,532 | $10,483 | 13.2% |
| 82310 | Calcium level, total | Office | 2023 | 968 | 2,023 | $111,265 | $10,236 | 9.2% |
| 82565 | Blood creatinine level | Office | 2023 | 973 | 2,031 | $101,550 | $10,196 | 10.0% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 23 | 596 | $77,480 | $10,045 | 13.0% |
| 84295 | Blood sodium level | Office | 2023 | 969 | 2,023 | $101,150 | $9,528 | 9.4% |
| 84100 | Phosphate level | Office | 2023 | 971 | 2,023 | $117,334 | $9,399 | 8.0% |
About Dr. Renwick Goldberg, MD
Dr. Renwick Goldberg, MD is a Hematology & Oncology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679566178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renwick Goldberg, MD has received a total of $973.09 in payments from pharmaceutical and medical device companies, with $175.72 received in 2024. These payments were reported across 54 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($924.21).
As a Medicare-enrolled provider, Goldberg has provided services to 72,648 Medicare beneficiaries, totaling 1,075,834 services with total Medicare billing of $11.6M. Data is available for 4 years (2020–2023), covering 334 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Myrtle Beach, SC
- Active Since 08/30/2005
- Last Updated 06/13/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1679566178
Products in Payments
- OPDIVO (Biological) $104.98
- ZEPZELCA (Drug) $93.16
- KISQALI (Drug) $92.03
- KEYTRUDA (Biological) $91.94
- IBRANCE (Drug) $50.00
- KRAZATI (Drug) $40.13
- PROMACTA (Drug) $35.12
- ADCETRIS (Biological) $30.56
- MEKINIST (Drug) $22.44
- SCEMBLIX (Drug) $21.41
- ENHERTU (Drug) $21.25
- Pomalyst (Drug) $21.11
- Doptelet (Drug) $19.25
- AKYNZEO (Drug) $17.62
- IMBRUVICA (Drug) $17.48
- PIQRAY (Drug) $17.34
- OJJAARA (Drug) $17.14
- BLENREP (Biological) $16.87
- GAZYVA (Biological) $16.19
- EPKINLY (Drug) $15.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Myrtle Beach
Dr. Emily Touloukian, D.o, D.O
Hematology & Oncology — Payments: $21,558
Hematology & Oncology $21,558
Dr. Dejuania Brown-Rawls, D.o, D.O
Hematology & Oncology — Payments: $6,918
Hematology & Oncology $6,918
Nicolina Scibelli
Hematology & Oncology — Payments: $4,838
Hematology & Oncology $4,838
Faria Ali, Md, MD
Hematology & Oncology — Payments: $1,550
Hematology & Oncology $1,550
Rebecca Cody, Md, MD
Hematology & Oncology — Payments: $1,356
Hematology & Oncology $1,356
Vijay Paudel, Md, MD
Hematology & Oncology — Payments: $1,134
Hematology & Oncology $1,134